Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
China
Beijing Cancer Hospital, Beijing Hunan Cancer Hospital, Changsha Cancer Hospital Affiliated to Shandong First Medical University (Shandong Cancer Hospital, Shandong cancer prevention and treatment institute), Jinan The First Affiliated Hospital of Xiamen University, Xiamen Henan Cancer Hospital, Zhengzhou